Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Press Releases

Investor Relations

Events & Presentations

Scientific Publications

Corporate Governance

Financial Information

Stock Information

Contact Us


All Releases
View Summary Aradigm Corporation Receives Nasdaq Notice of Non-Compliance With Nasdaq Marketplace Rules
Mar 31, 2006
PDF 11.5 KB Add to Briefcase
View Summary Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program of Novel Treatment for Asthma
Mar 23, 2006
PDF 13.4 KB Add to Briefcase
View Summary Aradigm Reports Novo Nordisk to Initiate Additional Phase 3 Clinical Trials of AERx Diabetes Management System
Mar 7, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm Corporation to Present at the Cowen & Co. 26th Annual Health Care Conference
Feb 28, 2006
PDF 10.5 KB Add to Briefcase
View Summary Aradigm Announces Fourth Quarter and Year End 2005 Financial Results
Feb 22, 2006
PDF 16.9 KB Add to Briefcase
View Summary Aradigm Corporation Fourth Quarter and Full Year 2005 Earnings and Conference Call Notification
Feb 15, 2006
PDF 11.0 KB Add to Briefcase
View Summary Aradigm Files Request for Orphan Drug Designation for Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
Jan 6, 2006
PDF 13.1 KB Add to Briefcase
Showing 221-227 of 227 Page: 1 ... 10 11 12  Previous 20
= add release to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2017 Aradigm Corporation. All Rights Reserved.